{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:33:39Z","timestamp":1778614419986,"version":"3.51.4"},"reference-count":73,"publisher":"Society of Nuclear Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,9,9]]},"published-print":{"date-parts":[[2024,11]]},"DOI":"10.2967\/jnumed.124.267948","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T19:10:25Z","timestamp":1727982625000},"page":"1745-1753","source":"Crossref","is-referenced-by-count":6,"title":["Cardiac Neuroendocrine Tumor Metastases on<sup>68<\/sup>Ga-DOTATATE PET\/CT: Identification and Prognostic Significance"],"prefix":"10.2967","volume":"65","author":[{"given":"Hwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad S.","family":"Alhamshari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Bhattaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitanya","family":"Rojulpote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh K.","family":"Vidula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Pryma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paco E.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"2025060410401062000_65.11.1745.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"2025060410401062000_65.11.1745.2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/ijem.IJEM_446_17","article-title":"Neuroendocrine neoplasms in rare locations: clinicopathological features and review of the literature","volume":"22","author":"Del Arco","year":"2018","journal-title":"Indian J Endocrinol Metab."},{"key":"2025060410401062000_65.11.1745.3","doi-asserted-by":"publisher","DOI":"10.1159\/000481390"},{"key":"2025060410401062000_65.11.1745.4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30400"},{"key":"2025060410401062000_65.11.1745.5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"key":"2025060410401062000_65.11.1745.6","doi-asserted-by":"publisher","DOI":"10.1159\/000443167"},{"key":"2025060410401062000_65.11.1745.7","doi-asserted-by":"publisher","DOI":"10.1159\/000287255"},{"key":"2025060410401062000_65.11.1745.8","doi-asserted-by":"publisher","DOI":"10.1159\/000286700"},{"key":"2025060410401062000_65.11.1745.9","doi-asserted-by":"publisher","DOI":"10.1159\/000287277"},{"key":"2025060410401062000_65.11.1745.10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12020-014-0272-4","article-title":"Myocardial metastases from neuroendocrine tumors: incidence and relevance","volume":"47","author":"Kwekkeboom","year":"2014","journal-title":"Endocrine."},{"key":"2025060410401062000_65.11.1745.11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1267204"},{"key":"2025060410401062000_65.11.1745.12","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.5858\/2002-126-1538-MCTTCS","article-title":"Metastatic carcinoid to the conducting system: is it a rare or merely unrecognized manifestation of carcinoid cardiopathy?","volume":"126","author":"Shehata","year":"2002","journal-title":"Arch Pathol Lab Med."},{"key":"2025060410401062000_65.11.1745.13","doi-asserted-by":"crossref","first-page":"300060520931678","DOI":"10.1177\/0300060520931678","article-title":"Cardiac metastasis of neuroendocrine tumor of the thymus diagnosed by cardiac magnetic resonance T1 mapping: a case report","volume":"48","author":"Zhang","year":"2020","journal-title":"J Int Med Res."},{"key":"2025060410401062000_65.11.1745.14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1752-1947-1-95","article-title":"External beam irradiation of myocardial carcinoid metastases: a case report","volume":"1","author":"Strosberg","year":"2007","journal-title":"J Med Case Rep."},{"key":"2025060410401062000_65.11.1745.15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12020-013-0108-7","article-title":"68Ga-DOTA-TOC-PET\/CT detects heart metastases from ileal neuroendocrine tumors","volume":"47","author":"Calissendorff","year":"2014","journal-title":"Endocrine."},{"key":"2025060410401062000_65.11.1745.16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MNM.0000000000000464","article-title":"Cardiac neuroendocrine tumour metastases: case reports and review of the literature","volume":"37","author":"Bonsen","year":"2016","journal-title":"Nucl Med Commun."},{"key":"2025060410401062000_65.11.1745.17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol."},{"key":"2025060410401062000_65.11.1745.18","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27994-2_20"},{"key":"2025060410401062000_65.11.1745.19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12350-022-03111-4","article-title":"Potential clinical utility of 68Ga-DOTATATE PET\/CT for detection and response assessment in cardiac sarcoidosis","volume":"30","author":"Lee","year":"2023","journal-title":"J Nucl Cardiol."},{"key":"2025060410401062000_65.11.1745.20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s12350-022-03090-6","article-title":"Detection of acute myocarditis by ECG-triggered PET imaging of somatostatin receptors compared to cardiac magnetic resonance: preliminary results","volume":"30","author":"Boursier","year":"2023","journal-title":"J Nucl Cardiol."},{"key":"2025060410401062000_65.11.1745.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(19)33095-5"},{"key":"2025060410401062000_65.11.1745.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012848"},{"key":"2025060410401062000_65.11.1745.23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/MNM.0000000000001064","article-title":"The heart matters: a review of incidental cardiac uptake on Ga-68 DOTA peptide PET-CT scans","volume":"40","author":"Moyade","year":"2019","journal-title":"Nucl Med Commun."},{"key":"2025060410401062000_65.11.1745.24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40644-018-0168-2","article-title":"Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT","volume":"18","author":"Kunz","year":"2018","journal-title":"Cancer Imaging."},{"key":"2025060410401062000_65.11.1745.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000790"},{"key":"2025060410401062000_65.11.1745.26","doi-asserted-by":"crossref","first-page":"e112278","DOI":"10.1371\/journal.pone.0112278","article-title":"Myocardial metastases on 6-[18F] fluoro-L-DOPA PET\/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients","volume":"9","author":"Noordzij","year":"2014","journal-title":"PLoS One."},{"key":"2025060410401062000_65.11.1745.27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1159\/000510444","article-title":"Cardiac metastases in patients with neuroendocrine tumours: clinical features, therapy outcomes, and prognostic implications","volume":"111","author":"Liu","year":"2021","journal-title":"Neuroendocrinology."},{"key":"2025060410401062000_65.11.1745.28","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/RLU.0000000000003283","article-title":"The use of peptide receptor radionuclide therapy in patients with neuroendocrine tumor cardiac metastases","volume":"46","author":"Yu","year":"2021","journal-title":"Clin Nucl Med."},{"key":"2025060410401062000_65.11.1745.29","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1007\/s00259-019-04448-8","article-title":"First-in-human 18F-SiFAlin-TATE PET\/CT for NET imaging and theranostics","volume":"46","author":"Ilhan","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025060410401062000_65.11.1745.30","doi-asserted-by":"crossref","first-page":"e8622","DOI":"10.1002\/ccr3.8622","article-title":"Radioligand therapy (RLT) used to treat cardiac metastasis of pancreatic neuroendocrine tumor","volume":"12","author":"Ved","year":"2024","journal-title":"Clin Case Rep."},{"key":"2025060410401062000_65.11.1745.31","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1097\/RLU.0000000000002905","article-title":"Twelve-year survival of a patient with lymph node, pulmonary, bone, cardiac and intraspinal metastases of a rectal neuroendocrine neoplasm treated with peptide receptor radionuclide therapy: the value of salvage peptide receptor radionuclide therapy","volume":"45","author":"Zhang","year":"2020","journal-title":"Clin Nucl Med."},{"key":"2025060410401062000_65.11.1745.32","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MPA.0000000000001101","article-title":"Cardiac toxicity in a patient receiving peptide receptor radionuclide therapy","volume":"47","author":"Hendifar","year":"2018","journal-title":"Pancreas."},{"key":"2025060410401062000_65.11.1745.33","doi-asserted-by":"crossref","first-page":"e13088","DOI":"10.1111\/jne.13088","article-title":"Treatment of neuroendocrine tumours with 177Lu-peptide receptor radionuclide therapy: challenging clinical scenarios and their management","volume":"34","author":"Navalkissoor","year":"2022","journal-title":"J Neuroendocrinol."},{"key":"2025060410401062000_65.11.1745.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.04.093"},{"key":"2025060410401062000_65.11.1745.35","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00259-023-06257-6","article-title":"The relationship between tumour dosimetry, response, and overall survival in patients with unresectable neuroendocrine neoplasms (NEN) treated with 177Lu DOTATATE (LuTate)","volume":"50","author":"Alipour","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025060410401062000_65.11.1745.36","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1007\/s12350-023-03345-w","article-title":"Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET\/CT and cardiac MRI","volume":"30","author":"Arnfield","year":"2023","journal-title":"J Nucl Cardiol."},{"key":"2025060410401062000_65.11.1745.37","doi-asserted-by":"crossref","unstructured":"El Ghannudi S Ouvrard E Mikail N Leroy Freschini B Schindler TH Imperiale A . Cutting-edge imaging of cardiac metastases from neuroendocrine tumors: lesson from a case series. Diagnostics (Basel). 2022;12:1182.","DOI":"10.3390\/diagnostics12051182"},{"key":"2025060410401062000_65.11.1745.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02109-5"},{"key":"2025060410401062000_65.11.1745.39","first-page":"70","article-title":"Octreotide: a review of its use in treating neuroendocrine tumours","volume":"10","author":"Costa","year":"2014","journal-title":"Eur Endocrinol."},{"key":"2025060410401062000_65.11.1745.40","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1159\/000518651","article-title":"Clinical features and prognosis of patients with carcinoid syndrome and carcinoid heart disease: a retrospective multicentric study of 276 patients","volume":"112","author":"Fijalkowski","year":"2022","journal-title":"Neuroendocrinology."},{"key":"2025060410401062000_65.11.1745.41","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12350-019-01782-0","article-title":"Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: a pilot study","volume":"28","author":"Bravo","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2025060410401062000_65.11.1745.42","first-page":"4971","article-title":"Somatostatin receptor immunohistochemistry in neuroendocrine tumors: comparison between manual and automated evaluation","volume":"7","author":"Kaemmerer","year":"2014","journal-title":"Int J Clin Exp Pathol."},{"key":"2025060410401062000_65.11.1745.43","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.035774"},{"key":"2025060410401062000_65.11.1745.44","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.acra.2021.10.004","article-title":"Combined quantification of 18F-FDG and 68Ga-DOTATATE PET\/CT for prognosis in high-grade gastroenteropancreatic neuroendocrine neoplasms","volume":"29","author":"Lee","year":"2022","journal-title":"Acad Radiol."},{"key":"2025060410401062000_65.11.1745.45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1634\/theoncologist.2020-0165","article-title":"68Ga-DOTATATE positron emission tomography-computed tomography quantification predicts response to somatostatin analog therapy in gastroenteropancreatic neuroendocrine tumors","volume":"26","author":"Lee","year":"2021","journal-title":"Oncologist."},{"key":"2025060410401062000_65.11.1745.46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/cancers16010200","article-title":"Prediction of 177Lu-DOTATATE therapy outcomes in neuroendocrine tumor patients using semi-automatic tumor delineation on 68Ga-DOTATATE PET\/CT","volume":"16","author":"Lee","year":"2023","journal-title":"Cancers (Basel)."},{"key":"2025060410401062000_65.11.1745.47","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1093\/ehjci\/jeae120","article-title":"Multimodality assessment of cardiac metastasis in a patient with ileal carcinoid","volume":"25","author":"Soroa","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"2025060410401062000_65.11.1745.48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40658-022-00487-7","article-title":"Comparison of image quality and spatial resolution between 18F, 68Ga, and 64Cu phantom measurements using a digital Biograph Vision PET\/CT","volume":"9","author":"Braune","year":"2022","journal-title":"EJNMMI Phys."},{"key":"2025060410401062000_65.11.1745.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-1030-8"},{"key":"2025060410401062000_65.11.1745.50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5603\/CJ.2017.0011","article-title":"18-FDG PET\/CT to reveal cardiac metastasis of pancreatic neuroendocrine cancer","volume":"24","author":"Jagielak","year":"2017","journal-title":"Cardiol J."},{"key":"2025060410401062000_65.11.1745.51","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/RLU.0000000000000963","article-title":"Cardiac metastases of neuroendocrine tumors treated with 177Lu DOTATATE peptide receptor radionuclide therapy or 131I-MIBG therapy","volume":"40","author":"Makis","year":"2015","journal-title":"Clin Nucl Med."},{"key":"2025060410401062000_65.11.1745.52","doi-asserted-by":"crossref","first-page":"e011857","DOI":"10.1161\/CIRCIMAGING.120.011857","article-title":"Early diagnosis and treatment of myocardial neuroendocrine tumor metastasis: the cornerstone role of multimodality imaging","volume":"14","author":"Mikail","year":"2021","journal-title":"Circ Cardiovasc Imaging."},{"key":"2025060410401062000_65.11.1745.53","doi-asserted-by":"publisher","DOI":"10.1148\/rg.315115003"},{"key":"2025060410401062000_65.11.1745.54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41416-022-02061-5","article-title":"Dual [68Ga]DOTATATE and [18F]FDG PET\/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score","volume":"128","author":"Chan","year":"2023","journal-title":"Br J Cancer."},{"key":"2025060410401062000_65.11.1745.55","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.4923"},{"key":"2025060410401062000_65.11.1745.56","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4997\/jrcpe.2020.409","article-title":"Retrospective studies: utility and caveats","volume":"50","author":"Talari","year":"2020","journal-title":"J R Coll Physicians Edinb."},{"key":"2025060410401062000_65.11.1745.57","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181bc7bd5"},{"key":"2025060410401062000_65.11.1745.58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jccase.2023.05.002","article-title":"A case of cardiac metastasis of neuroendocrine tumor with 2-year follow-up","volume":"28","author":"Shibata","year":"2023","journal-title":"J Cardiol Cases."},{"key":"2025060410401062000_65.11.1745.59","doi-asserted-by":"crossref","first-page":"ytaa550","DOI":"10.1093\/ehjcr\/ytaa550","article-title":"Added-value of molecular imaging in myocardial metastasis of an ileal neuroendocrine tumour treated with peptide receptor radionuclide therapy: a case report","volume":"5","author":"Mall\u00f3n Araujo","year":"2021","journal-title":"Eur Heart J Case Rep."},{"key":"2025060410401062000_65.11.1745.60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2169\/internalmedicine.5208-20","article-title":"Cardiac metastasis caused fatal ventricular arrhythmia in a patient with a rectal neuroendocrine tumor","volume":"60","author":"Ando","year":"2021","journal-title":"Intern Med."},{"key":"2025060410401062000_65.11.1745.61","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa364"},{"key":"2025060410401062000_65.11.1745.62","first-page":"72","article-title":"Isolated cardiac metastases of pulmonary carcinoid detected 13 years after resection of the primary tumor","volume":"130","author":"Niemiec-Plich","year":"2020","journal-title":"Pol Arch Intern Med."},{"key":"2025060410401062000_65.11.1745.63","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.2459\/JCM.0000000000000054","article-title":"An unusual case of metastatic carcinoid tumour in the interventricular septum","volume":"17","author":"Yan","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)."},{"key":"2025060410401062000_65.11.1745.64","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s12020-015-0712-9","article-title":"Interventricular septum metastasis in neuroendocrine tumour","volume":"53","author":"Castello","year":"2016","journal-title":"Endocrine."},{"key":"2025060410401062000_65.11.1745.65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4143\/crt.2013.45.2.150","article-title":"Multiple cardiac metastases from a nonfunctioning pancreatic neuroendocrine tumor","volume":"45","author":"Choi","year":"2013","journal-title":"Cancer Res Treat."},{"key":"2025060410401062000_65.11.1745.66","first-page":"282","article-title":"Metastatic carcinoid tumor obstructing left ventricular outflow","volume":"38","author":"Chrysant","year":"2011","journal-title":"Tex Heart Inst J."},{"key":"2025060410401062000_65.11.1745.67","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.coc.0000236006.54867.f7","article-title":"Metastatic midgut carcinoid to the heart demonstrated on cardiac magnetic resonance imaging","volume":"32","author":"Pasieka","year":"2009","journal-title":"Am J Clin Oncol."},{"key":"2025060410401062000_65.11.1745.68","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.767111"},{"key":"2025060410401062000_65.11.1745.69","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl237"},{"key":"2025060410401062000_65.11.1745.70","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1200\/JCO.2000.18.7.1596","article-title":"Case 2: myocardial metastases from a carcinoid tumor","volume":"18","author":"Penz","year":"2000","journal-title":"J Clin Oncol."},{"key":"2025060410401062000_65.11.1745.71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12350-018-1426-1","article-title":"Large cardiac metastasis from pancreatic neuroendocrine tumor and response to peptide receptor radionuclide therapy with 177Lu-DOTATATE","volume":"27","author":"Parghane","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"2025060410401062000_65.11.1745.72","doi-asserted-by":"crossref","unstructured":"Rosseel L Everaert H Weytjens C Droogmans S . Epicardial mass and valvular heart disease: what is the relation? Med Res Arch. 2016;4:1\u201314.","DOI":"10.18103\/mra.v4i8.746"},{"key":"2025060410401062000_65.11.1745.73","first-page":"161","article-title":"A patient with medullary thyroid carcinoma and right ventricular cardiac metastasis treated by 90Y-Dotatoc","volume":"12","author":"Bertagna","year":"2009","journal-title":"Hell J Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.267948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:40:59Z","timestamp":1749058859000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.267948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":73,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,1]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.2967\/jnumed.124.267948"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.267948","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}